ArticleExperimental & molecular medicine2022

DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapy.

Haejeong Heo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.